These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

755 related items for PubMed ID: 3114569

  • 1. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
    Frey JR, Kamber M, Peck R.
    Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ, Ronteltap CP, Gravekamp C, Monnikendam D, Bolhuis RL.
    J Immunol; 1986 Mar 01; 136(5):1700-7. PubMed ID: 3005399
    [Abstract] [Full Text] [Related]

  • 4. Induction by interferon-alpha of tumoricidal activity of adherent mononuclear cells from human blood: monocytes as responder and effector cells.
    Sone S, Utsugi T, Shirahama T, Ishii K, Mutsuura S, Ogawara M.
    J Biol Response Mod; 1985 Apr 01; 4(2):134-40. PubMed ID: 3998764
    [Abstract] [Full Text] [Related]

  • 5. Protection of cultured human monocytes from lymphokine-activated killer-mediated lysis by IFN-gamma.
    Blanchard DK, Djeu JY.
    J Immunol; 1988 Dec 01; 141(11):4067-73. PubMed ID: 2460557
    [Abstract] [Full Text] [Related]

  • 6. [Induction of human monocyte-mediated tumor cell killing by alpha or beta interferon].
    Utsugi T, Mutsuura S, Ogawara M, Shirahama T, Ishii K, Tsubura E, Sone S.
    Gan To Kagaku Ryoho; 1985 May 01; 12(5):1105-10. PubMed ID: 3994398
    [Abstract] [Full Text] [Related]

  • 7. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
    Grönberg A, Ferm MT, Ng J, Reynolds CW, Ortaldo JR.
    J Immunol; 1988 Jun 15; 140(12):4397-402. PubMed ID: 3131433
    [Abstract] [Full Text] [Related]

  • 8. Role of serotonin in the regulation of human natural killer cell cytotoxicity.
    Hellstrand K, Hermodsson S.
    J Immunol; 1987 Aug 01; 139(3):869-75. PubMed ID: 2439597
    [Abstract] [Full Text] [Related]

  • 9. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T, Belfrage H, Bhiladvala P, Hedlund G.
    J Immunol; 1987 Jun 01; 138(11):3640-5. PubMed ID: 3495566
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of human natural killer cell function by the combined effects of tumor necrosis factor alpha or interleukin-1 and interferon-alpha or interleukin-2.
    Ostensen ME, Thiele DL, Lipsky PE.
    J Biol Response Mod; 1989 Feb 01; 8(1):53-61. PubMed ID: 2493514
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells.
    Ostensen ME, Thiele DL, Lipsky PE.
    J Immunol; 1987 Jun 15; 138(12):4185-91. PubMed ID: 3108384
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.
    Sampson-Johannes A, Carlino JA.
    J Immunol; 1988 Nov 15; 141(10):3680-6. PubMed ID: 3053901
    [Abstract] [Full Text] [Related]

  • 15. Cytolysis of tumor necrosis factor (TNF)-resistant tumor targets. Differential cytotoxicity of monocytes activated by the interferons, IL-2, and TNF.
    Philip R.
    J Immunol; 1988 Feb 15; 140(4):1345-9. PubMed ID: 2449501
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development.
    Ueno Y, Miyawaki T, Seki H, Matsuda A, Taga K, Sato H, Taniguchi N.
    J Immunol; 1985 Jul 15; 135(1):180-4. PubMed ID: 3923100
    [Abstract] [Full Text] [Related]

  • 17. Interplay in vitro between ACTH, beta-endorphin, and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer (NK) cell activity.
    Gatti G, Masera RG, Pallavicini L, Sartori ML, Staurenghi A, Orlandi F, Angeli A.
    Brain Behav Immun; 1993 Mar 15; 7(1):16-28. PubMed ID: 8386029
    [Abstract] [Full Text] [Related]

  • 18. IFN-alpha and IFN-gamma can affect both monocytes and tumor cells to modulate monocyte-mediated cytotoxicity.
    Webb DS, Gerrard TL.
    J Immunol; 1990 May 01; 144(9):3643-8. PubMed ID: 2158515
    [Abstract] [Full Text] [Related]

  • 19. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    Peters PM, Ortaldo JR, Shalaby MR, Svedersky LP, Nedwin GE, Bringman TS, Hass PE, Aggarwal BB, Herberman RB, Goeddel DV.
    J Immunol; 1986 Oct 15; 137(8):2592-8. PubMed ID: 3760569
    [Abstract] [Full Text] [Related]

  • 20. TLR8-driven IL-12-dependent reciprocal and synergistic activation of NK cells and monocytes by immunostimulatory RNA.
    Berger M, Ablasser A, Kim S, Bekeredjian-Ding I, Giese T, Endres S, Hornung V, Hartmann G.
    J Immunother; 2009 Apr 15; 32(3):262-71. PubMed ID: 19242374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.